Skip to main content
. 2017 Mar 25;96(6):905–917. doi: 10.1007/s00277-017-2970-5

Fig. 5.

Fig. 5

Effect of inhibition of TNF or IL-1β on TF mRNA levels in NB4 cells. NB4 cells were exposed for 24 h to various concentrations of adalimumab (a TNF inhibitory antibody) or anakinra (an IL-1 receptor antagonist) and TF mRNA levels were quantified by qPCR and expressed relative to that of the corresponding mRNA in control (unexposed cells, incubated in medium alone) NB4 cells. Results are expressed as means ± SEM of six independent experiments